SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001387131-20-004224
Filing Date
2020-04-29
Accepted
2020-04-28 21:48:13
Documents
14
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDED 10-K txmd-10ka_123119.htm   iXBRL 10-K/A 491754
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-3.htm EX-31.3 3220
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-4.htm EX-31.4 3259
  Complete submission text file 0001387131-20-004224.txt   784004

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20191231.xsd EX-101.SCH 3469
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20191231_lab.xml EX-101.LAB 35203
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20191231_pre.xml EX-101.PRE 23106
9 EXTRACTED XBRL INSTANCE DOCUMENT txmd-10ka_123119_htm.xml XML 5833
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-00100 | Film No.: 20827101
SIC: 2834 Pharmaceutical Preparations